(Q36579646)

15 August 2017

1 reference

title

PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients (English)

1 reference

15 August 2017

Keigo Endo

1

1 reference

15 August 2017

Noboru Oriuchi

2

1 reference

15 August 2017

Tetsuya Higuchi

3

1 reference

15 August 2017

Yasuhiko Iida

4

1 reference

15 August 2017

Hirofumi Hanaoka

5

1 reference

15 August 2017

Mitsuyuki Miyakubo

6

1 reference

15 August 2017

Tomohiro Ishikita

7

1 reference

15 August 2017

Keiko Koyama

8

1 reference

15 August 2017

language of work or name

1 reference

1 August 2006

1 reference

International Journal of Clinical Oncology

15 August 2017

1 reference

15 August 2017

11

1 reference

15 August 2017

4

1 reference

15 August 2017

286-296

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-006-0595-0

15 August 2017

0 references

cites work

Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer

1 reference

12 December 2020

18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies

1 reference

12 December 2020

Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer

1 reference

12 December 2020

The role of positron emission tomography in the management of bone metastases

1 reference

12 December 2020

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

1 reference

12 December 2020

PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.

1 reference

12 December 2020

Role of positron emission tomography in lymphoma

1 reference

12 December 2020

Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography

1 reference

12 December 2020

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography

1 reference

12 December 2020

In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET

1 reference

12 December 2020

Seeking a home for a PET, part 1: Defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or masses

1 reference

12 December 2020

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

1 reference

12 December 2020

Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer

1 reference

12 December 2020

Clinical role of FDG PET in evaluation of cancer patients

1 reference

12 December 2020

18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.

1 reference

12 December 2020

Initial and subsequent approach for the synthesis of 18FDG

1 reference

12 December 2020

Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings

1 reference

12 December 2020

Utility of FDG-PET scanning in lymphoma by WHO classification

1 reference

12 December 2020

The solitary pulmonary nodule

1 reference

12 December 2020

Clinical applications of PET in oncology

1 reference

12 December 2020

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations

1 reference

12 December 2020

Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis

1 reference

12 December 2020

Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery

1 reference

12 December 2020

Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake

1 reference

12 December 2020

The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study.

1 reference

12 December 2020

Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis

1 reference

12 December 2020

Combined PET/CT colonography: is this the way forward?

1 reference

12 December 2020

Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making.

1 reference

12 December 2020

Positron-emission tomography and assessment of cancer therapy

1 reference

12 December 2020

A tabulated summary of the FDG PET literature.

1 reference

12 December 2020

The contribution of PET/CT to improved patient management

1 reference

12 December 2020

Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma

1 reference

12 December 2020

Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.

1 reference

12 December 2020

Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: technical feasibility and first experiences in patients with colorectal cancer

1 reference

12 December 2020

Seeking a home for a PET, part 3: Emerging applications of positron emission tomography imaging in the management of patients with lung cancer

1 reference

12 December 2020

Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose

1 reference

12 December 2020

Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas

1 reference

12 December 2020

Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.

1 reference

12 December 2020

A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer

1 reference

12 December 2020

Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET).

1 reference

12 December 2020

Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

1 reference

12 December 2020

Integrated PET/CT: current applications and future directions

1 reference

12 December 2020

18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer

1 reference

12 December 2020

FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.

1 reference

12 December 2020

Seeking a home for a PET, part 2: Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer

1 reference

12 December 2020

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

12 December 2020

18F-FDG PET detection of colonic adenomas

1 reference

12 December 2020

The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.

1 reference

12 December 2020

PET evaluation of lung cancer

1 reference

12 December 2020

Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma

1 reference

12 December 2020

A combined PET/CT scanner for clinical oncology.

1 reference

12 December 2020

10.1007/S10147-006-0595-0

Identifiers

DOI

1 reference

15 August 2017

1 reference